Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fedor Simko

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Expert Review of Clinical Pharmacology|March 3, 2018
What prevents cardioprotective drugs from reaching the market?Fedor Simko, Michaela Adamcova
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 28, 2009
Chronic antioxidant therapy fails to ameliorate hypertension: potential mechanisms behindOlga Pechanova, Fedor Simko
Journal of Pineal Research|March 6, 2008
Chronotherapy beyond blood pressure reduction?Fedor Simko, Ludovit Paulis
Clinical and Experimental Pharmacology & Physiology|February 22, 2019
Ivabradine reversed nondipping heart rate in rats with l-NAME-induced hypertensionTomas Baka, Fedor Simko
Journal of Hypertension|August 17, 2012
Hypertensive heart disease: bone marrow as a significant player in pathologic remodelling?Fedor Simko, Ludovit Paulis
Journal of Hypertension|September 9, 2010
The role of nuclear factor kappa B and nitric oxide interaction in heart remodellingOlga Pechanova, Fedor Simko
Therapeutic Advances in Chronic Disease|April 25, 2022
Chronotherapy of cardiovascular pathologies: a hopeful strategyFedor Simko, Tomas Baka
Frontiers in Pharmacology|February 14, 2022
Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial CellsFedor Simko, Tomas Baka
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 28, 2009
Recent trends in hypertension treatment: perspectives from animal studiesFedor Simko, Olga Pechanova
International Journal of Cardiology|April 25, 2013
Antifibrotic effect of melatonin--perspective protection in hypertensive heart diseaseFedor Simko, Ludovit Paulis
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Expert Review of Clinical Pharmacology|March 3, 2018
What prevents cardioprotective drugs from reaching the market?Fedor Simko, Michaela Adamcova
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 28, 2009
Chronic antioxidant therapy fails to ameliorate hypertension: potential mechanisms behindOlga Pechanova, Fedor Simko
Journal of Pineal Research|March 6, 2008
Chronotherapy beyond blood pressure reduction?Fedor Simko, Ludovit Paulis
Clinical and Experimental Pharmacology & Physiology|February 22, 2019
Ivabradine reversed nondipping heart rate in rats with l-NAME-induced hypertensionTomas Baka, Fedor Simko
Journal of Hypertension|August 17, 2012
Hypertensive heart disease: bone marrow as a significant player in pathologic remodelling?Fedor Simko, Ludovit Paulis
Journal of Hypertension|September 9, 2010
The role of nuclear factor kappa B and nitric oxide interaction in heart remodellingOlga Pechanova, Fedor Simko
Therapeutic Advances in Chronic Disease|April 25, 2022
Chronotherapy of cardiovascular pathologies: a hopeful strategyFedor Simko, Tomas Baka
Frontiers in Pharmacology|February 14, 2022
Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial CellsFedor Simko, Tomas Baka
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 28, 2009
Recent trends in hypertension treatment: perspectives from animal studiesFedor Simko, Olga Pechanova
International Journal of Cardiology|April 25, 2013
Antifibrotic effect of melatonin--perspective protection in hypertensive heart diseaseFedor Simko, Ludovit Paulis
Pageof 9